Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5H95B | — |
patient needed a polio vaccine and they accidentally gave Kinrix; Wrong age/17 year old patient needed a polio vaccine and they accidentally gave Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 17-year-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. Co-suspect products included Polio vaccine for prophylaxis. Previously administered products included Pediarix (received in JAN-2008 from lot number AC21B125BB), Pediarix (received in MAR-2008 from lot number AC21B136CA), Pediarix (received in MAY-2008 from lot number AC21B136CA), Ipol (received in JAN-2008), Ipol (received in 16-MAY-2008), Daptacel (received in MAR-2008), Daptacel (received in MAR-2009), Adacel (received in FEB-2019) and Adacel (received in 19-OCT-2020). On 10-MAR-2025, the patient received Kinrix. On an unknown date, the patient did not receive Polio vaccine. On 10-MAR-2025, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: patient needed a polio vaccine and they accidentally gave Kinrix) and inappropriate age at vaccine administration (Verbatim: Wrong age/17 year old patient needed a polio vaccine and they accidentally gave Kinrix). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-MAR-2025 and 12-MAR-2025 Manager explained that a patient needed a polio vaccine, and they accidentally gave Kinrix without noticing that it was not recommended for that age, which led to wrong vaccine administered and inappropriate age at vaccine administration. The patient was administered a dose of Kinrix due to their facility not having a supply of an appropriate vaccine for polio for the patient's age group. The reporter confirmed the patient has not reported any medical concerns or symptoms after being administered the Kinrix. The patient received Prior doses of Diphtheria, Tetanus, Pertussis and Poliovirus vaccines: was received DTaP-Hib combined vaccine (unknown brand) in December 2011. No additional information provided. No additional AE/PQC (adverse event or product quality complaint provided).